Cadila Healthcare has informed that financial results of the company for Q2 2021-22 (July-September 2021) would be declared on October 29, 2021. Post results Q&A session through teleconference has been scheduled on the same day October 29, 2021 at 4:00 pm. Sharvil Patel, Managing Director of the Company would be hosting the call. The call will be conducted through the audio webcast format. The link to join the call is attached.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1937.05 |
| Dr. Reddys Labs. | 1247.55 |
| Cipla | 1444.05 |
| Zydus Lifesciences | 1157.10 |
| Lupin | 2508.90 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: